企業プロフィール
Vanda Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- VNDA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
5.28 USD (-1.86%)
終値
最終更新: 2026年8月21日
369M USD
時価総額
株価変動の要因
As of Aug 21, 2026, VNDA closed down 1.86% at $5.28. No new same-company headline was identified in the current news window.
企業概要
事業概要
Vanda Pharmaceuticals is a specialty pharma company with an emphasis on neuroscience and sleep-related therapies. Its business has long centered on commercial products and selective pipeline development.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Vanda sits in specialty biopharma.
ビジネスモデルの特徴
The company depends on product revenue, label positioning, and the ability to build new assets around a concentrated commercial base.
バイオ業界での位置付け
Vanda is a commercial specialty-pharma name whose valuation is tied to product durability and pipeline optionality.
今後のカタリスト
- Vanda’s catalysts are HETLIOZ and Fanapt execution, plus any regulatory or litigation update tied to the sleep franchise. The stock usually moves when the company shows that the commercial base can stay durable.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。